Article
Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells
2020-11-12
Abstract excerpt
The secretory pathway Ca 2+ -ATPase SPCA2 is a tumor suppressor in triple receptor negative breast cancer (TNBC), a highly aggressive molecular subtype that lacks tailored treatment options. Low expression of SPCA2 in TNBC confers poor survival prognosis in patients. Previous work has established that re-introducing SPCA2 to TNBC cells restores basal Ca 2+ signaling, represses mesenchymal gene expression, mitiga...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 34166bca-cdb2-58d4-9f8f-3f35c8b37c60
- DOI
- 10.1101/2020.11.12.379685
